Kevin Kabler is a partner in Goodwin’s nationally recognized Life Sciences group. His practice focuses on developing and implementing value-creating patent portfolio strategies for emerging and mature life sciences companies. Dr. Kabler integrates with his clients, fully understands their business goals, and works directly with them to build comprehensive and efficient patent portfolio strategies to advance those goals.
Dr. Kabler’s practice also involves strategic patent counseling and intellectual property due diligence for his life sciences clients, including companies and investors. His diligence work includes acting as lead patent counsel on behalf of his clients in mergers, acquisitions, and strategic partnership formation with pharmaceutical and biotechnology companies. He has extensive experience advising his clients in assessing competitive landscapes, complex intellectual property assets, associated risks, and thoughtful mitigation of those risks. His deep diligence experience and strategic insights have made him one of the most preferred diligence counsel in California for life sciences companies and their investors.
Representative Matters
Professional Experience
Prior to joining Goodwin in 2019, Dr. Kabler was a partner at Fenwick & West LLP. Before joining Fenwick & West, he was a post-doctoral fellow in the laboratory of Nobel Laureate J. Michael Bishop at the University of California, San Francisco.
Credentials
Education
JD
University of California College of the Law, San Francisco
(magna cum laude, Order of the Coif, Thurston Honor Society)
PhDImmunology
Baylor College of Medicine
BSMicrobiology
Kansas State University
(cum laude)
Admissions
Bars
- California
- U.S. Patent and Trademark Office (USPTO)
Recognition & Awards
Kevin Kabler was ranked by Chambers USA 2024 and 2025 for his work in Intellectual Property: Patent Prosecution. Kevin has also been named a Patent Star (nationwide and California) and Notable Practitioner (California) by Managing IP.